Last 12 months
Inside the activity.
9 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 2, 2026 23:01 UTC |
Bonnefoy LucPresident, Surgical
|
Tax withholdingCommon Shares, No Par Value | 9,221 | $18.30 | $168,744.30 |
DisclosureSEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 3 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,001 F2 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 23:01 UTC |
Bonnefoy LucPresident, Surgical
|
Tax withholdingCommon Shares, No Par Value | 4,311 | $18.30 | $78,891.30 |
DisclosureSEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,222 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:46 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
Tax withholdingCommon Shares, No Par Value | 2,461 | $18.30 | $45,036.30 |
DisclosureSEC source: 0001860742-26-000043 · form4.xml · nonDerivative · entry 2 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,290 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:45 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 51,470 | $18.30 | $941,901.00 |
DisclosureSEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 3 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,130 F2 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:45 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 15,507 | $18.30 | $283,778.10 |
DisclosureSEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,600 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:44 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Shares, No Par Value | 24,649 | $18.30 | $451,076.70 |
DisclosureSEC source: 0001860742-26-000041 · form4.xml · nonDerivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 951,875 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:24 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 4,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000050 · form4.xml · nonDerivative · entry 2 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,814 F1 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:24 UTC |
VON ESCHENBACH ANDREW C.Director
|
PurchaseCommon Shares, No Par Value | 4,364 | $18.31 | $79,883.02 |
DisclosureSEC source: 0001860742-26-000050 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,450 Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 23:00 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 2,169 | $18.49 | $40,104.81 |
DisclosureSEC source: 0001860742-26-000045 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,737 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 23:04 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 2,042 | $18.49 | $37,756.58 |
DisclosureSEC source: 0001860742-26-000048 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,442 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 23:03 UTC |
Stewart Andrew J.President, GPIC
|
Tax withholdingCommon Shares, No Par Value | 2,984 | $18.49 | $55,174.16 |
DisclosureSEC source: 0001860742-26-000047 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · President, GPIC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,656 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 23:01 UTC |
Bonnefoy LucPresident, Surgical
|
Tax withholdingCommon Shares, No Par Value | 4,404 | $18.49 | $81,429.96 |
DisclosureSEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,533 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:46 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
Tax withholdingCommon Shares, No Par Value | 3,395 | $18.49 | $62,773.55 |
DisclosureSEC source: 0001860742-26-000043 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,751 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:45 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 7,062 | $18.49 | $130,576.38 |
DisclosureSEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,107 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:44 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Shares, No Par Value | 22,059 | $18.49 | $407,870.91 |
DisclosureSEC source: 0001860742-26-000041 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 976,524 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:18 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantCommon Shares, No Par Value | 35,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000035 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,906 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:27 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 18,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000039 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,484 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:26 UTC |
Bonnefoy LucPresident, Surgical
|
GrantCommon Shares, No Par Value | 30,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000038 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,937 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:24 UTC |
Stewart Andrew J.President, GPIC
|
GrantCommon Shares, No Par Value | 32,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000037 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · President, GPIC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,640 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:13 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantCommon Shares, No Par Value | 52,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000033 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,146 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:04 UTC |
Eldessouky SamEVP and CFO
|
GrantCommon Shares, No Par Value | 81,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000029 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,169 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
GrantCommon Shares, No Par Value | 327,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000028 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998,583 F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:23 UTC |
COLLIS STEVEN HDirector
|
GrantCommon Shares, No Par Value | 4,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000022 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,746 F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:23 UTC |
COLLIS STEVEN HDirector
|
PurchaseCommon Shares, No Par Value | 15,000 | $17.81 | $267,150.00 |
DisclosureSEC source: 0001860742-26-000022 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,255 F1 · price: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.77 to $17.85 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:58 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Shares, No Par Value | 65,444 | $17.99 | $1,177,337.56 |
DisclosureSEC source: 0001860742-26-000027 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 671,481 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:16 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000021 · form4.xml · nonDerivative · entry 2 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,807 F1 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:16 UTC |
ROBERTSON RUSSEL CDirector
|
PurchaseCommon Shares, No Par Value | 4,400 | $17.90 | $78,760.00 |
DisclosureSEC source: 0001860742-26-000021 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,407 Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:20 UTC |
Ling KarenDirector
|
GrantCommon Shares, No Par Value | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000020 · form4.xml · nonDerivative · entry 2 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,676 F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances). Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:20 UTC |
Ling KarenDirector
|
PurchaseCommon Shares, No Par Value | 4,000 | $17.74 | $70,968.00 |
DisclosureSEC source: 0001860742-26-000020 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,676 F1 · price: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.71 to $17.75 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:19 UTC |
COLLIS STEVEN HDirector
|
GrantCommon Shares, No Par Value | 5,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000019 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,255 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:17 UTC |
Alfonso EduardoDirector
|
GrantCommon Shares, No Par Value | 5,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000018 · form4.xml · nonDerivative · entry 1 Alfonso Eduardo · CIK 0002104484 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,255 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:11 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,451 | $17.65 | $25,610.15 |
DisclosureSEC source: 0001860742-26-000017 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,007 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:09 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,239 | $17.65 | $21,868.35 |
DisclosureSEC source: 0001860742-26-000016 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,606 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:39 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantCommon Shares, No Par Value | 29,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000011 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,860 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:44 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 12,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000015 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,231 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:42 UTC |
Bonnefoy LucPresident, Surgical
|
GrantCommon Shares, No Par Value | 10,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000013 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,564 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:34 UTC |
Eldessouky SamEVP and CFO
|
GrantCommon Shares, No Par Value | 70,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001860742-26-000009 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,394 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:42 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,642 | $15.60 | $25,615.20 |
DisclosureSEC source: 0001860742-25-000032 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,556 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:23 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,402 | $15.60 | $21,871.20 |
DisclosureSEC source: 0001860742-25-000027 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,367 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:40 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantCommon Shares, No Par Value | 17,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020239 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,454 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:48 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 7,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020243 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,733 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:46 UTC |
Eldessouky SamEVP and CFO
|
GrantCommon Shares, No Par Value | 42,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020242 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,816 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:42 UTC |
Bonnefoy LucPresident, Surgical
|
GrantCommon Shares, No Par Value | 6,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020240 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,362 F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:23 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Shares, No Par Value | 4,231 | $14.44 | $61,095.64 |
DisclosureSEC source: 0001127602-25-020237 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 736,925 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 22:34 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 2,841 | $14.32 | $40,683.12 |
DisclosureSEC source: 0001127602-25-019687 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,739 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 22:12 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 1,090 | $14.32 | $15,608.80 |
DisclosureSEC source: 0001127602-25-019665 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,204 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 22:19 UTC |
Bonnefoy LucPresident, Surgical
|
Tax withholdingCommon Shares, No Par Value | 2,167 | $14.32 | $31,031.44 |
DisclosureSEC source: 0001127602-25-019670 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,216 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 21:53 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 3,996 | $14.32 | $57,222.72 |
DisclosureSEC source: 0001127602-25-019662 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,299 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 21:35 UTC |
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
|
GrantPerformance Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-097980 · ownership.xml · derivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Shares, No Par Value · 900,000 shares Expires not disclosed F1 · derivative.exercise_price: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan. F2 · derivative.exercise_price: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date. F3 · derivative.exercise_price: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment. F1 · derivative.exercise_date: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan. F2 · derivative.exercise_date: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date. F3 · derivative.exercise_date: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment. F1 · derivative.expiration_date: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan. F2 · derivative.expiration_date: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date. F3 · derivative.expiration_date: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment. F1 · derivative.underlying_shares: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan. F2 · derivative.underlying_shares: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date. F3 · derivative.underlying_shares: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment. F1 · balance_after: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan. F2 · balance_after: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date. F3 · balance_after: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:46 UTC |
Bonnefoy LucPresident, Surgical
|
Tax withholdingCommon Shares, No Par Value | 968 | $12.33 | $11,935.44 |
DisclosureSEC source: 0001127602-25-017578 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,383 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.